Lu Dong

460 total citations
18 papers, 335 citations indexed

About

Lu Dong is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Lu Dong has authored 18 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Lu Dong's work include Identity, Memory, and Therapy (3 papers), Stroke Rehabilitation and Recovery (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). Lu Dong is often cited by papers focused on Identity, Memory, and Therapy (3 papers), Stroke Rehabilitation and Recovery (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). Lu Dong collaborates with scholars based in China, United States and France. Lu Dong's co-authors include Xin Luan, Jinmei Jin, Sanhong Liu, Weidong Zhang, Ye Wu, Yudong Zhou, Hongzhuan Chen, Feng Zhang, Xin Xu and Hua‐Wu Zeng and has published in prestigious journals such as Journal of Medicinal Chemistry, Science Advances and Advanced Science.

In The Last Decade

Lu Dong

14 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Dong China 11 149 66 53 45 39 18 335
Rajni Khan India 7 200 1.3× 49 0.7× 40 0.8× 43 1.0× 31 0.8× 12 574
Tamina Park South Korea 9 93 0.6× 53 0.8× 19 0.4× 24 0.5× 51 1.3× 16 287
V. Parthasarathy India 10 127 0.9× 37 0.6× 22 0.4× 32 0.7× 21 0.5× 44 390
Sahar Qazi India 9 122 0.8× 32 0.5× 26 0.5× 23 0.5× 35 0.9× 23 258
Hongyuan Shen Singapore 10 177 1.2× 24 0.4× 25 0.5× 51 1.1× 42 1.1× 28 460
Deepa S. Mandlik India 10 95 0.6× 43 0.7× 80 1.5× 38 0.8× 8 0.2× 26 360
Pingrong Yang China 10 215 1.4× 33 0.5× 28 0.5× 26 0.6× 30 0.8× 16 348
Lixin Li China 10 212 1.4× 32 0.5× 16 0.3× 17 0.4× 27 0.7× 14 351
Mohanapriya Arumugam India 13 158 1.1× 29 0.4× 23 0.4× 23 0.5× 77 2.0× 39 421
Moein Shirzad Iran 12 130 0.9× 25 0.4× 27 0.5× 39 0.9× 23 0.6× 42 481

Countries citing papers authored by Lu Dong

Since Specialization
Citations

This map shows the geographic impact of Lu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Dong more than expected).

Fields of papers citing papers by Lu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Dong. The network helps show where Lu Dong may publish in the future.

Co-authorship network of co-authors of Lu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Dong. A scholar is included among the top collaborators of Lu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Dong. Lu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Li, Xin, Feng An, You Wang, et al.. (2025). Comparative Analysis of Drought-Driven Water-Use Strategies in Mangroves and Forests. Forests. 16(3). 396–396.
3.
4.
Dong, Lu, et al.. (2025). The impact of pilot Low-carbon city policies on urban energy ecological efficiency. Economic Analysis and Policy. 87. 1014–1031. 2 indexed citations
5.
6.
Li, Yifan, Nan Wang, Lu Dong, et al.. (2024). Prodrug-inspired adenosine triphosphate–activatable celastrol-Fe(III) chelate for cancer therapy. Science Advances. 10(28). eadn0960–eadn0960. 13 indexed citations
7.
Liang, Xiaohui, Lu Dong, Jiayi Lin, et al.. (2024). In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77‐PPARγ Interaction and Its Anti‐Breast‐Cancer Efficacy. Advanced Science. 11(26). e2308435–e2308435. 7 indexed citations
8.
Sun, Jie, Mingyue Zhang, Yaqing Zhang, et al.. (2024). Effect of Acupuncture on Cognitive Function in Patients With Post‐Stroke Cognitive Impairment: A Systematic Review and Meta‐Analysis. Brain and Behavior. 14(10). e70075–e70075. 1 indexed citations
9.
Chen, Guo, Hongjie Zhang, Lu Dong, et al.. (2024). EgoExoLearn: A Dataset for Bridging Asynchronous Ego- and Exo-centric View of Procedural Activities in Real World. 22072–22086. 12 indexed citations
10.
Sun, Jie, Yiyan Wang, Mingyue Zhang, et al.. (2023). The Efficacy of Reminiscence Therapy in Cancer-Related Symptom Management: A Systematic Review and Meta-Analysis. Integrative Cancer Therapies. 22. 1553462635–1553462635. 12 indexed citations
11.
Liu, Xiaoxia, Jinmei Jin, Ye Wu, et al.. (2023). Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy. European Journal of Medicinal Chemistry. 257. 115540–115540. 15 indexed citations
12.
Lv, Chao, Yun Huang, Rui Huang, et al.. (2022). Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells. Molecular Therapy — Oncolytics. 24. 340–354. 25 indexed citations
13.
Huang, Rui, Lijun Zhang, Jinmei Jin, et al.. (2021). Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharmaceutica Sinica B. 11(11). 3481–3492. 51 indexed citations
14.
Wu, Ye, Lu Dong, Yixin Jiang, et al.. (2021). Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma. Journal of Medicinal Chemistry. 64(9). 5802–5815. 37 indexed citations
15.
Wang, Qun, Yun Huang, Min Jia, et al.. (2021). Safflower Polysaccharide Inhibits AOM/DSS-Induced Mice Colorectal Cancer Through the Regulation of Macrophage Polarization. Frontiers in Pharmacology. 12. 761641–761641. 18 indexed citations
16.
Yang, Ting, Yixin Jiang, Ye Wu, et al.. (2021). Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Frontiers in Pharmacology. 12. 682735–682735. 14 indexed citations
17.
18.
Lü, Qian, Lu Dong, Ivan H. C. Wu, et al.. (2018). The impact of an expressive writing intervention on quality of life among Chinese breast cancer patients undergoing chemotherapy. Supportive Care in Cancer. 27(1). 165–173. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajni Khan Breakdown of academic impact, for papers by Tamina Park Breakdown of academic impact, for papers by V. Parthasarathy Breakdown of academic impact, for papers by Sahar Qazi Breakdown of academic impact, for papers by Hongyuan Shen Breakdown of academic impact, for papers by Deepa S. Mandlik Breakdown of academic impact, for papers by Pingrong Yang Breakdown of academic impact, for papers by Lixin Li Breakdown of academic impact, for papers by Mohanapriya Arumugam Breakdown of academic impact, for papers by Moein Shirzad
Rankless by CCL
2026